Sangeetha Shenoy, Divya Nagabushana, Kumar Sunil, Ar Somashekar, Chandrika Rao
Department of Peadiatrics, Ramaiah Medical College, Bangalore, India.
Iran J Child Neurol. 2024 Fall;18(4):47-60. doi: 10.22037/ijcn.v18.43364. Epub 2024 Sep 29.
Neurological manifestations of Severe Acute Respiratory Syndrome coronavirus-2 have been well documented in adults during and after infection with the virus as well as after vaccination. The incidence of severe neurological symptoms among children is very low. This study aimed to analyze the varied neurological manifestations after COVID-19 infection among children and give a report on a single-center experience with these severe neurological symptoms.
MATERIALS & METHODS: Case records of patients less than 18 years admitted between July 2021 to December 2022 with neurological manifestations and COVID-19 infection or with elevated COVID-19 antibodies after exclusion of other etiological diagnosis were analyzed.
There were 10 cases in the age range of 1-15 years. All the cases had elevated COVID-19 antibodies with history of contact 2-3 weeks prior except one who was positive for COVID-19 infection. Two cases presented with acute ascending paralysis suggestive of Guillain-Barre syndrome. Four cases presented with features of encephalopathy with clinical presentation fulfilling the criteria of Multisystem inflammatory syndrome in children. One case presented with fever and focal seizures with MRI showing sagittal sinus thrombosis, and one presented with fever and altered sensorium with MRI showing leukoencephalopathy. One child had cerebral mucormycosis without any evidence of immunosuppression. There was one child with features of encephalopathy with active COVID-19 infection.
The varied presentation highlights the central and peripheral nervous system involvement by the virus in the pediatric population. It also emphasizes the need to investigate for COVID-19 in children presenting with these complaints during the pandemic.
严重急性呼吸综合征冠状病毒2在成人感染期间、感染后以及接种疫苗后出现的神经学表现已有充分记录。儿童中严重神经症状的发生率非常低。本研究旨在分析儿童感染新冠病毒后出现的各种神经学表现,并报告单中心处理这些严重神经症状的经验。
分析2021年7月至2022年12月期间收治的18岁以下出现神经学表现且感染新冠病毒或排除其他病因诊断后新冠病毒抗体升高的患者的病例记录。
有10例年龄在1至15岁之间。除1例新冠病毒感染呈阳性外,所有病例的新冠病毒抗体均升高,且有2至3周前的接触史。2例表现为提示吉兰-巴雷综合征的急性上行性麻痹。4例表现为脑病特征,临床表现符合儿童多系统炎症综合征的标准。1例出现发热和局灶性癫痫发作,磁共振成像显示矢状窦血栓形成,1例出现发热和意识改变,磁共振成像显示白质脑病。1名儿童患有脑毛霉菌病,无任何免疫抑制证据。有1名患有脑病特征且新冠病毒感染活跃的儿童。
多样的表现突出了病毒在儿童人群中对中枢和周围神经系统的累及。这也强调了在大流行期间对出现这些症状的儿童进行新冠病毒调查的必要性。